83 related articles for article (PubMed ID: 1436379)
1. High concentrations of dopamine and epinephrine protect dopaminergic D2 receptors from inactivation by phenoxybenzamine on primary cultured rat lactotrophs.
Shin SH; Heisler RL
Neuroendocrinology; 1992 Sep; 56(3):407-14. PubMed ID: 1436379
[TBL] [Abstract][Full Text] [Related]
2. Phenoxybenzamine selectively and irreversibly inactivates dopaminergic D2 receptors on primary cultured rat lactotrophs.
Shin SH; McAssey K; Heisler RL; Szabo MS
Neuroendocrinology; 1992 Sep; 56(3):397-406. PubMed ID: 1436378
[TBL] [Abstract][Full Text] [Related]
3. Activation of the adrenergic beta-receptor stimulates prolactin release from primary cultured pituitary cells.
Shin SH; Barton RE
Neuroendocrinology; 1993 Apr; 57(4):670-7. PubMed ID: 8396220
[TBL] [Abstract][Full Text] [Related]
4. Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro.
Meller E; Puza T; Miller JC; Friedhoff AJ; Schweitzer JW
J Pharmacol Exp Ther; 1991 May; 257(2):668-75. PubMed ID: 1674531
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of receptor inactivation, 17 beta-estradiol and pertussis toxin on dopaminergic inhibition of prolactin secretion in vitro.
Meller E; Puza T; Diamond J; Lieu HD; Bohmaker K
J Pharmacol Exp Ther; 1992 Nov; 263(2):462-9. PubMed ID: 1359107
[TBL] [Abstract][Full Text] [Related]
6. Inverse agonism at dopamine D2 receptors. Haloperidol-induced prolactin release from GH4C1 cells transfected with the human D2 receptor is antagonized by R(-)-n-propylnorapomorphine, raclopride, and phenoxybenzamine.
Nilsson CL; Ekman A; Hellstrand M; Eriksson E
Neuropsychopharmacology; 1996 Jul; 15(1):53-61. PubMed ID: 8797192
[TBL] [Abstract][Full Text] [Related]
7. Dopamine requires ascorbic acid to be the prolactin release-inhibiting factor.
Shin SH; Si F; Chang A; Ross GM
Am J Physiol; 1997 Sep; 273(3 Pt 1):E593-8. PubMed ID: 9316450
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
Burris TP; Stringer LC; Freeman ME
Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
[TBL] [Abstract][Full Text] [Related]
9. Dopamine agonist action of phencyclidine.
Seeman P; Lasaga M
Synapse; 2005 Dec; 58(4):275-7. PubMed ID: 16206157
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of dopamine and bromocriptine on induced prolactin release: multiple sites for the inhibition of dopamine.
Hanna S; Shin SH
Neuroendocrinology; 1992 May; 55(5):591-9. PubMed ID: 1316563
[TBL] [Abstract][Full Text] [Related]
11. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
Pisarek H; Stepien H; Pawlikowski M
Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis.
De Laurentiis A; Pisera D; Caruso C; Candolfi M; Mohn C; Rettori V; Seilicovich A
Neuroimmunomodulation; 2002; 10(1):30-9. PubMed ID: 12207161
[TBL] [Abstract][Full Text] [Related]
13. Absence of coupling between D2 dopamine receptors and calcium channels in lactotrophs from cycling female rats.
Rendt J; Oxford GS
Endocrinology; 1994 Aug; 135(2):501-8. PubMed ID: 8033799
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D2 receptor mediates both inhibitory and stimulatory actions on prolactin release.
Chang A; Shin SH; Pang SC
Endocrine; 1997 Oct; 7(2):177-82. PubMed ID: 9549043
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of delta 9-tetrahydrocannabinol on tuberoinfundibular dopamine activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle.
Bonnin A; Ramos JA; RodrÃguez de Fonseca F; Cebeira M; Fernández-Ruiz JJ
Neuroendocrinology; 1993 Sep; 58(3):280-6. PubMed ID: 7902959
[TBL] [Abstract][Full Text] [Related]
16. Activation of D2 dopamine receptors inhibits estrogen response element-mediated estrogen receptor transactivation in rat pituitary lactotrophs.
Ishida M; Mitsui T; Izawa M; Arita J
Mol Cell Endocrinol; 2013 Aug; 375(1-2):58-67. PubMed ID: 23701824
[TBL] [Abstract][Full Text] [Related]
17. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
18. Partial dopamine D2 receptor agonists antagonize prolactin-regulating D2 receptors in a transfected clonal cell line (GH4ZR7).
Nilsson C; Eriksson E
Eur J Pharmacol; 1992 Aug; 218(2-3):205-11. PubMed ID: 1358634
[TBL] [Abstract][Full Text] [Related]
19. D2 dopamine-receptor-mediated inhibition of proliferation of rat lactotropes in culture is accompanied by changes in cell shape.
Arita J; Hashi A; Hoshi K; Mazawa S; Suzuki S
Neuroendocrinology; 1998 Sep; 68(3):163-71. PubMed ID: 9734000
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the pituitary effects of the mammalian endothelins: vasoactive intestinal contractor (endothelin-beta, rat endothelin-2) is a potent inhibitor of prolactin secretion.
Samson WK; Skala KD
Endocrinology; 1992 May; 130(5):2964-70. PubMed ID: 1533364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
